Beauty and wellness solutions provider Nu Skin’s fourth-quarter diluted earnings per share (EPS) surged 94% to $1.40 year-on-year, beating the Street consensus of $1.19.
Meanwhile, 4Q sales grew 28% year-on-year to $748.2 million, but missed analysts’ expectations by $1.5 million. Nu Skin’s (NUS) gross margin dipped from 75.9% to 74% during the reported period due to higher freight charges and geographic mix.
For fiscal 2020, Nu Skin’s revenue increased to $2.58 billion from $2.42 billion year-on-year. Earnings grew to $3.63 per share from $3.10 per share during the same comparative period.
Nu Skin CEO Ritch Wood commented, “Strong 4Q results were driven by 34% year-on-year customer growth. The manufacturing segment posted 42% revenue growth despite global supply chain constraints.”
Looking ahead, Nu Skin forecasted first quarter revenue to come in between $610 million to $640 million on EPS of between $0.65 to $0.75. (See Nu Skin stock analysis on TipRanks)
The company sees fiscal 2021 revenues in the range of $2.71 billion to $2.81 billion and EPS to generate between $3.80 to $4.10. Wood added, “The company expects a strong 2021 on the back of robust product pipeline and digital initiatives in combination with growth in customers and sales leaders.”
Nu Skin stock has had a stellar run surging more than 80% over the past year.
Earlier this month, Jefferies analyst Stephanie Wissink raised the stock’s price target from $60 to $66 (5% upside potential) and reiterated a Buy rating. Stephanie cited FX developments and timing of the company’s ageLOC Boost launch as the factors for lifting his PT. She also remains constructive over the favourable wellness backdrop.
Related News:
Twitter Quarterly Sales Outperform Driven By Ad Revenue; Shares Rise
Cisco Drops 4.6% Pre-Market On Flat Sales Growth In 2Q
Lyft Sees Recovery Path After 4Q Sales Outperform; Shares Spike 13%
